Relation of stent design and stent surface material to subsequent in-stent intimal hyperplasia in coronary arteries determined by intravascular ultrasound

https://doi.org/10.1016/S0002-9149(02)02347-0Get rights and content

Abstract

A variety of different stent designs and coatings have become available. This study sought to determine the impact of stent design and gold-coating of stents on intimal hyperplasia (IH) in human atherosclerotic coronary arteries in relation to known predictors of restenosis. Angiographic and intravascular ultrasound (IVUS) studies were performed at 6-month follow-up on 311 native coronary lesions of 311 patients treated with 99 Multi-Link stents, 74 InFlow steel stents, 73 InFlow gold-coated stents, 41 Palmaz-Schatz stents, 12 NIR steel stents, and 12 gold-coated NIR Royal stents. Lumen and stent cross-sectional area (CSA) were measured at 1-mm axial increments. Mean IH CSA (stent CSA − lumen CSA) and mean IH thickness were calculated and averaged over the total stent length. IVUS demonstrated different levels of IH for the 6 stents. Mean IH thickness ranged from 0.20 ± 0.13 mm for Multi-Link stents to 0.43 ± 0.14 mm for InFlow goal-coated stents (p <0.001). Multivariate analysis proved non–Multi-Link stent design (odds ratio 3.45, 95% confidence intervals 1.13 to 11.11, p <0.034) and gold coating (odds ratio 3.78, 95% confidence intervals 1.88 to 7.54, p <0.001) to be the only independent predictors of IH thickness >0.3 mm. In conclusion, stent design and surface material have an important impact on the IH response to stents implanted in human coronary arteries. However, the differences in IH thickness between the analyzed stents were relatively small compared with the absolute lumen dimensions.

Section snippets

Patients and lesions:

Consecutive patients from 4 studies who required IVUS follow-up at 6 months were included in this study. A differenct stent design was used in each study. Lesion inclusion criteria were similar for the 4 studies. Coronary lesions had to be located in a native artery of 2.5 to 4.0 mm diameter and lesion length (up to 15 mm for Multi-Link stents [Guidant, Santa Clara, California], Palmaz-Schatz stents [Johnson & Johnson, Warren, New Jersey), and NIR stents [Scimed, Maple Grove, Michigan], and up

Results

Patient demographics are listed in Table 1.

Discussion

This IVUS study on 4 different stent designs and 2 different stent surface materials indicates that stent design, stent surface material, and diabetes mellitus have an important impact on the amount of IH thickness after coronary stent placement.

References (23)

  • P.W. Serruys et al.

    A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease

    N Engl J Med

    (1994)
  • Cited by (67)

    • Chiral constrained stent: Effect of structural design on the mechanical and intravascular stent deployment performances

      2020, Mechanics of Materials
      Citation Excerpt :

      Some auxiliary method like the generation of radio-opaque coatings, surface modification with inorganic coatings and drug delivery/eluting with Polymer coatings have been well studied, and the bare metal stent still plays a basic role (Loew et al., 2009). Efforts have been devoted to collecting adequate randomized clinical implantation results to statistically guide the proper stent parameters design (Nikolsky et al., 2003; Kastrati et al., 2001; Hoffmann et al., 2002), exploring the key factors of existing stent topologies that affect the stenting performance (Hsiao et al., 2012; Pant et al., 2011; Putra et al., 2019; Shen et al., 2019) and developing suitable cutting-edge bio-materials (O'Brien and Carroll, 2009; O'Brien et al., 2010; Khosravi et al., 2017; Praveen Kumar et al., 2016). Since there exists no general scheme for the design and evaluation of intravascular stent system which shall cover multi-disciplinary fields, the diagram as we summarized in Figure A.1 may provide some guidance for future researchers in the field.

    • Assessment of structural and hemodynamic performance of vascular stents modelled as periodic lattices

      2018, Medical Engineering and Physics
      Citation Excerpt :

      Stents that shorten can result in the clinician missing the target zone resulting in the deployment of a secondary stent. Stents with low elongation on expansion have had a lower reported incidence and rate of restenosis compared to other bare-metal stents [47–50]. Restenosis has also been linked to the change in blood flow around the stent [23].

    • Restenosis of the Coronary Arteries: Past, Present, Future Directions

      2016, Interventional Cardiology Clinics
      Citation Excerpt :

      Early preclinical studies suggested that restenotic responses may be affected by certain biomechanical aspects (architecture, material composition, and strut thickness) of the stent, independent of vessel injury.88,89 Several randomized trials now support the notion that stent characteristics, particularly strut size, may affect the risk of restenosis.90,91 For instance, the ISAR-STEREO 2 (Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome) trial showed that use of the thin strut (50 μm) RX multilink (Guidant, Advanced Cardiovascular Systems, Santa Clara, CA) resulted in marked reduction in binary restenosis and TVR (12.3% vs 21.9%) compared with the thick strut (140 μm) BX velocity (Cordis Corporation, Miami, FL).91

    • An analytical solution for the stress state at stent-coating interfaces

      2012, Journal of the Mechanical Behavior of Biomedical Materials
      Citation Excerpt :

      Upon stent deployment the coating is debonded from the metallic surfaces and the debonded polymer material is stretched between adjacent struts. Several studies have suggested that coating damage plays a significant role in the development of clinical complications such as thrombosis, micro-embolism formation and impaired drug delivery (Hoffmann et al., 2002; Otsuka et al., 2007; Levy et al., 2009; Balakrishnan et al., 2005). In-vivo evidence of coating damage and associated clinical complications has been reported in animal and human trials: Kollum et al. (2005) reported debris from a nanoporous aluminum oxide coating was surrounded by inflammation in the arterial sections post stent placement.

    View all citing articles on Scopus
    View full text